Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-05

Clinical Trial Update: β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed

View source ↗

Summary

A completed clinical trial suggests that β-cell function in Type 1 diabetes mellitus may not be as low as previously thought.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gonca Incemehmet Tamer | Conditions: TYPE 1 DIABETES | Status: COMPLETED